triple cart regimen
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 30, 2021 (NCT04892654)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigen
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04892654 | Phase 3 | Sep 30, 2021 | Chelsea and Westminster Hospital NHS Foundation Trust, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chelsea and Westminster Hospital NHS Foundation Trust | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1